Exploring the Resistance Mechanism of Osimertinib and Monitoring the Treatment Response Using Plasma ctDNA in Chinese NSCLC Patients

被引：9
|
作者：
Shi, Y. [1 ,2 ]
Xing, P. [1 ,2 ]
Han, X. [3 ,4 ]
Wang, S. [5 ]
Liu, Y. [1 ,2 ]
Liu, P. [1 ,2 ]
Li, J. [1 ,2 ]
Chang, L. [5 ]
Guan, Y. [5 ]
Zhang, Z. [1 ,2 ]
Wu, D. [1 ,2 ]
Yao, J. [1 ,2 ]
Xin, Y. [5 ]
机构：
[1] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Clin Lab, Beijing, Peoples R China
[4] Peking Union Med Coll, Beijing 100021, Peoples R China
[5] Geneplus Beijing Inst, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
plasma ctDNA; non-small cell lung cancer; Resistance;
D O I：
10.1016/j.jtho.2018.08.875
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13-18
引用
收藏
页码：S589 / S589
页数：1
相关论文
共 50 条
  • [21] Quantification and Monitoring of Treatment Response in EGFR Mutant NSCLC Patients by Digital-PCR in Plasma cftDNA
    Ludovini, Vienna
    Siggillino, Annamaria
    Reda, Maria Sole
    Bianconi, Fortunato
    Chiari, Rita
    Baglivo, Sara
    Pistola, Lorenza
    Tofanetti, Francesca Romana
    Matocci, Roberta
    Mencaroni, Clelia
    Metro, Giulio
    Bennati, Chiara
    Minotti, Vincenzo
    Crino, Lucio
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1189 - S1190
  • [22] Plasma ctDNA multigene mutation analysis for the diagnosis and treatment monitoring of colorectal cancer patients
    Powell, Michael J.
    Peletskaya, Elena
    Sun, Qing
    Du, Jinwei
    Pastor, Larry
    Phatak, Jyoti
    Wilding, Jenny
    Bodmer, Walter F.
    Zhang, Aiguo
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients
    Wu, Y.
    Chen, Y.
    Wu, G.
    Zhang, H.
    Lu, Y.
    Cheng, Y.
    Hu, Y.
    Liang, Z.
    Wang, J.
    Ying, J.
    Liu, W.
    Zhang, X.
    Liang, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S867 - S867
  • [24] A prospective study of NSCLC patients investigating treatment response and resistance mutations
    Laszkowski, Jana
    Forster, Michael
    Hemmrich-Stanisak, Georg
    Franke, Andre
    Frank, Malene Stochkel
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [25] Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
    Vidal, J.
    Muinelo, L.
    Dalmases, A.
    Jones, F.
    Edelstein, D.
    Iglesias, M.
    Orrillo, M.
    Abalo, A.
    Rodriguez, C.
    Brozos, E.
    Vidal, Y.
    Candamio, S.
    Vazquez, F.
    Ruiz, J.
    Guix, M.
    Visa, L.
    Sikri, V.
    Albanell, J.
    Bellosillo, B.
    Lopez, R.
    Montagut, C.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1325 - 1332
  • [26] Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR- Mutated NSCLC
    Buder, Anna
    Hochmair, Maximilian J.
    Schwab, Sophia
    Bundalo, Tatjana
    Schenk, Peter
    Errhalt, Peter
    Mikes, Romana E.
    Absenger, Gudrun
    Patocka, Kurt
    Baumgartner, Bernhard
    Setinek, Ulrike
    Burghuber, Otto C.
    Prosch, Helmut
    Pirker, Robert
    Filipits, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 821 - 830
  • [27] Combining plasma-based biosources to predict treatment response in NSCLC patients
    Bracht, J. W. P.
    Berenguer, J.
    Karachaliou, N.
    Filipska, M.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2018, 29 (09) : 2022 - 2022
  • [28] Use of CTTA to predict treatment response in patients with EGFR T790M1 NSCLC treated with osimertinib
    Tan, W. L.
    Nguyen, T. A. Tran
    Koh, T. S.
    Hennedige, T. Priyanthi
    Yip, C. S. P.
    Tan, S. H.
    Tan, D. S. W.
    Thng, C. H.
    Lim, D. W-T.
    Ng, Q. S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Associations of ctDNA clearance and pathological response with neoadjuvant treatment in patients with resectable NSCLC from the phase III AEGEAN trial
    Reck, M.
    Gale, D.
    Harpole, D.
    Taube, J. M.
    Mitsudomi, T.
    Hochmair, M. J.
    Winder, T.
    Zhu, Z.
    Lai, Z.
    Stewart, R.
    Hodgson, D. R.
    Doherty, G. J.
    Heymach, J. V.
    ANNALS OF ONCOLOGY, 2023, 34 : S1300 - S1300
  • [30] DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment
    Ntzifa, Aliki
    Londra, Dora
    Rampias, Theodoros
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    Lianidou, Evi
    CANCERS, 2021, 13 (23)
12345